| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.31 | 0.06 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.22 | 0.08 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.076 | 0.08 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.09 |